baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out LLY/ DE000GG2XMP6 /

2024-05-17 9:57:10 PM	Chg.-0.25	Bid10:00:43 PM	Ask10:00:43 PM	Underlying	Strike price	Expiration date	Option type
11.21EUR	-2.18%	- Bid Size: -	- Ask Size: -	Eli Lilly and Co	648.2319 USD	2078-12-31	Call

GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 05-08 Erasca Reports First Quarter 2024 Business Updates and Financial Results

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors

GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

TeleTrader 04-30 Eli Lilly's Q1 revenue surges 26% to $8.8B

GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

GlobeNewswire 04-29 Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...

GlobeNewswire 04-26 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...

GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 04-22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

GlobeNewswire 04-22 TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology...

GlobeNewswire 04-17 89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

GlobeNewswire 04-15 CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

GlobeNewswire 04-15 Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endo...

GlobeNewswire 04-10 Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atop...

GlobeNewswire 04-09 Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors

GlobeNewswire 04-09 AskBio Names Mansuo Shannon Chief Scientific Officer

GlobeNewswire 04-05 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

Goldman Sachs Knock-Out LLY/ DE000GG2XMP6 /

If you wish to receive reply to your feedback, please provide your email address.